Clinical Trials Arena on MSN
AiCuris reports positive Phase III pritelivir results for HSV patients
The trial enrolled and treated 101 immunocompromised patients with refractory or resistant HSV infection.
Investigational antiviral pritelivir demonstrates efficacy and improved tolerability over current treatments for refractory HSV in high-risk patients.
Pritelivir met its primary endpoint of superior lesion healing, achieving a 62.7% lesion healing rate compared to 34.0% with standard-of-care ...
SV Elversberg has strengthens its midfield with the signing of Immanuel Pherai who arrives from Hamburger SV.Reportedly, a ...
Every single HSV supporter had been looking forward to this encounter for weeks or even months. On Saturday evening, the German record champions played a Bundesliga game at the Volksparkstadion in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results